News

Sylentis claimed that the trial result was positive. In the trial, the patients demonstrated local and systemic tolerance to SYL040012. The trial’s endpoint was to determine the tolerance

As per the terms of the sub-licensing agreement, T-Ray Science is expected to collect royalties on the sales of this product and any other products that utilise CW

US WorldMeds said the time to reconstitute dantrolene sodium for injection has been reduced to approximately 20 seconds or until the solution is clear and Revonto retains the

SBC-102 is a protein designed to be identical to the enzyme that is missing. It is being evaluated in preclinical studies as a potential enzyme replacement therapy, or

Esker said that organisations in the pharmaceutical and medical equipment industry receive thousands of sales orders daily from pharmacies, clinics, hospitals and doctors who use fax or postal

NextPharma claimed that the new line can fill capsules, coated tablets, tablets into various forms and sizes of bottles. Currently, the line is set up to provide six

Tamir said that Onconase is an RNase that overcomes the challenges of targeting RNA for therapeutic purposes while enabling the development of a new class of targeted therapies

In contradiction to the two approved HPV vaccines that target approximately 70% of HPV strains, Dynavax Technologies is into developing a vaccine that provides immunity to nearly all

Silence Therapeutics said that the patent is issued for the methods of producing double stranded (RNAi) agents having decreased off-target silencing activity through certain structural modifications. Apart from